We are live on ! Find out more
RAPP

Rapport Therapeutics
RAPP

124 hedge funds and large institutions have $1.46B invested in Rapport Therapeutics in 2025 Q3 according to their latest regulatory filings, with 51 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

467% more first-time investments, than exits

New positions opened: 51 | Existing positions closed: 9

234% more capital invested

Capital invested by funds: $438M → $1.46B (+$1.03B)

85% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 20

51% more funds holding

Funds holding: 82 → 124 (+42)

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

29.54% more ownership

Funds ownership: 105.47% → 135.01% (+30%)

17% more call options, than puts

Call options by funds: $7.6M | Put options by funds: $6.49M

Holders
124
Holders Change
+42
Holders Change %
+51.22%
% of All Funds
1.63%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.08%
New
51
Increased
37
Reduced
20
Closed
9
Calls
$7.6M
Puts
$6.49M
Net Calls
+$1.11M
Net Calls Change
+$1.12M

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$25.7M
2
Goldman Sachs
Goldman Sachs
New York
+$21.2M
3
BBA
Baker Bros. Advisors
New York
+$17.8M
4
VPC
Vestal Point Capital
New York
+$16.9M
5
PCH
Polar Capital Holdings
United Kingdom
+$16.7M

Top Sellers

Rank Fund Capital Flow
1
JJ
Johnson & Johnson
New Jersey
-$12.7M
2
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$7.55M
3
AllianceBernstein
AllianceBernstein
Tennessee
-$5.33M
4
SAM
Sectoral Asset Management
Quebec, Canada
-$2.43M
5
LGM
Logos Global Management
California
-$2.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
Franklin Resources
26
Franklin Resources
California
$7.44M +$4.47M +250,590 New
BGM
27
Burkehill Global Management
New York
$7.42M +$4.46M +250,000 New
SCM
28
Silverarc Capital Management
Massachusetts
$6.06M +$3.64M +203,946 New
Charles Schwab
29
Charles Schwab
California
$6.01M +$1.94M +108,952 +117%
Ensign Peak Advisors
30
Ensign Peak Advisors
Utah
$5.77M – – –
SCM
31
Sio Capital Management
New York
$5.5M +$3.3M +185,265 New
Invesco
32
Invesco
Georgia
$4.69M +$2.82M +157,984 New
SFM
33
Sphera Funds Management
Israel
$4.68M +$2.81M +157,533 New
Millennium Management
34
Millennium Management
New York
$4.58M +$2.75M +154,174 New
Northern Trust
35
Northern Trust
Illinois
$4.57M +$670K +37,584 +32%
EP
36
Eversept Partners
New York
$4.26M +$2.56M +143,565 New
TD Asset Management
37
TD Asset Management
Ontario, Canada
$4.07M -$1.07M -59,856 -30%
Ameriprise
38
Ameriprise
Minnesota
$3.71M +$2.23M +124,803 New
Citadel Advisors
39
Citadel Advisors
Florida
$3.11M +$1.87M +104,878 New
EI
40
EAM Investors
California
$2.55M +$1.56M +87,272 New
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$2.45M -$323K -18,093 -18%
FBCM
42
Fort Baker Capital Management
California
$2.42M +$1.46M +81,644 New
SCM
43
Soleus Capital Management
Connecticut
$2.38M +$1.43M +80,000 New
DCM
44
DAFNA Capital Management
California
$2.23M +$1.34M +75,000 New
MB
45
MPM BioImpact
Massachusetts
$2.13M +$1.28M +71,807 New
Walleye Capital
46
Walleye Capital
New York
$2.07M +$1.24M +69,570 New
AGP
47
Artia Global Partners
Florida
$1.92M +$1.15M +64,608 New
Wellington Management Group
48
Wellington Management Group
Massachusetts
$1.87M +$1.12M +62,822 New
Bank of America
49
Bank of America
North Carolina
$1.72M +$819K +45,934 +379%
SSA
50
Schonfeld Strategic Advisors
New York
$1.7M +$1.02M +57,148 New
1
2
3 4 5

RAPP Hedge Fund Activity: Q3 2025 in Review

124 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Rapport Therapeutics (RAPP) for Q3 2025, worth a combined $1.46B — up 234% from $438M a quarter earlier.

Buyers outnumbered sellers: 51 funds opened new RAPP positions and 9 closed out — a net gain of 42 holders — while 37 added to existing stakes and 20 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $25.7M. The largest seller was Johnson & Johnson, cutting an estimated $12.7M.

  • 124 institutional investors held Rapport Therapeutics (RAPP) as of Q3 2025, up from 82 in Q2 2025.
  • Funds reported $1.46B of Rapport Therapeutics stock for Q3 2025, up 234% quarter-over-quarter.
  • 51 funds opened new Rapport Therapeutics positions in Q3 2025 and 9 closed out, a net change of +42 holders.
  • The largest Rapport Therapeutics buyer in Q3 2025 was Fidelity Investments, an estimated $25.7M added.
  • The largest Rapport Therapeutics seller in Q3 2025 was Johnson & Johnson, an estimated $12.7M sold.

Based on aggregated 13F filings for Q3 2025.